Summary Statement

Computational models are the primary tools for efficient design-phase exploration of knee replacement concepts before in vitro testing. To improve design-phase efficiency, a subject-specific computational platform was developed that allows designers to assess devices in realistic conditions by directly integrating subject-specific experimental data in these models.

Intramedullary (IM) femoral alignment guide for unicondylar knee arthroplasty (UKA) is a classic and generally accepted technique to treat unicompartmental knee osteoarthritis. However, IM system has a risk of excessive blood loss, fat embolism and activation of coagulation.Moreover, the implant placement and limb alignment may be less accurate in IM for UKA than total knee arthroplasty. So we try to use extramedullary (EM) femoral alignment for UKA to avoid above disadvantages. To our knowledge, few current studies have been reported by now. We reported a series of cases treated through a newly developed EM technique and evaluated the accuracy of femoral component alignment and preliminary clinical results. Between January 2009 and January 2010, 11 consecutive patients(15 knees)consisting of 8 males and 3 females were enrolled. There were 7 cases in unilateral knee and 4 cases in bilateral knees. The mean age was 65.2 years (range 60∼72 years). Incision, surgical time, blood loss and complications were measured. The pre- and post operative function of the knees were evaluated by HSS score system. The pre- and postoperative femoral component alignment was measured and compared. All cases were followed up for average 15 months (10-22 months). The mean length of incision was 7.2cm (range 6 to 8cm), the mean surgical time was 115.0min(range 90 to 125min),the mean blood loss was 50.8ml (range 50 to 80ml). The mean preoperative HSS score increased from 75 (range 63 to 83) to 95 (range 88 to 97) postoperatively (p<0.05). All femoral components were within the recommended range for varus/valgus (±10 degree) and lexion/extension (±5 degree) angle. None had complications associated with reamed canal injury. By using our EM technique, we could achieve an accurate femoral component alignment and satisfactory clinical effect. However, strict comparison between EM and cconventional IM technique and large amount of cases are essential. Further mid- and long-term studies are required.

Myostatin (GDF-8) is known to play an important role in muscle regeneration, and myostatin is also expressed during the early phases of fracture healing. In this study we used fluorescent immunohistochemistry to define the temporal and spatial localization of myostatin during muscle and bone repair following deep penetrant injury in a mouse model. We then used hydrogel delivery of exogenous myostatin in the same injury model to determine the effects of myostatin exposure on muscle and bone healing. Results show that while myostatin was constitutively expressed in the cytoplasm of intact skeletal muscle fibers, a pool of intense myostatin staining was observed amongst injured skeletal muscle fibers 12-24 hours post-surgery. Myostatin was also expressed in the soft callus chondrocytes 4 days following osteotomy. Hydrogel delivery of 10 or 100 ug/ml recombinant myostatin decreased fracture callus cartilage area relative to total callus area in a dose-dependent manner by 41% and 80% (p<0.05), respectively, compared to vehicle treatment. Myostatin treatment also dose-dependently decreased fracture callus total bone volume by 23% and 47% (p<0.05), with the higher dose of recombinant myostatin yielding the greatest decrease in callus bone volume. Finally, exogenous myostatin treatment caused a significant, dose-dependent increase in fibrous tissue formation in skeletal muscle. Together, these findings suggest that myostatin may inhibit bone repair after traumatic musculoskeletal injury through both autocrine (soft-callus chondrocytes) and paracrine (surrounding injured muscle fibers) mechanisms. Thus, early pharmacological inhibition of myostatin is likely to improve the regenerative potential of both muscle and bone following deep penetrant musculoskeletal injury.

Great interest in unicompartmental knee arthroplasty (UKA) for medial osteoarthritis has rapidly increased following the introduction of minimally invasive UKA (MI-UKA). This approach preserves the normal anatomy of knee, causes less damage to extensor mechanism and results in a more rapid post-operative recovery. However, experience with this approach is limited in China. The aim of this report was to determine the short-term clinical and radiographic outcomes of MI-UKA in the Chinese, and to identify any features that are unique to this population. Fifty two knees, in forty-eight patients, with medial compartmental osteoarthritis treated by MI-UKA via C-arm intensifier guide (CAIG) from May 2005 to January 2009 were reviewed. Pain and range of motion (ROM) was assessed using the HSS scoring system before and after surgery. Pre- and postoperative alignment of the lower limbs was measured and compared. The mean follow up time was 24 months (12-42 months). In all cases the pain over medial compartment of the knees was relieved or subsided. The post-operative ROM was 0-136 degree (mean 122degree), and the mean alignment was 2degree varus (0- 7degree varus). The HSS score increased from 72(61-82) to 92(72-95). 93% of the postoperative scores were good or excellent. Interestingly, the distribution of femoral component sizes of these patients was XS 2%, Small 83%, Medium 15%, Large 0%, XL 0%; whereas tibial component size was AA 27%, A 55%, B 15%, C 3%, D 0%, E 0%, and F 0%. The optimal fitted match between tibial and femoral size was: tibia AA and A with XS and small femur, tibia B and C with medium femur. The estimated match was: tibia D and E with large femur, tibia F with XL femur. In contrast to the Oxford report, the sizes of these components are smaller and not in correlation with the height, weight and BMI of the patients. We conclude that MI-UKA is an effective method for treating medial compartmental osteoarthritis of the knee in the Chinese population. CAIG is a feasibly intraoperative measure to predict femoral component sizes. However, component sizes and combinations are different from the Oxford guideline.

Peri-tendinous injection of local anaesthetic, both alone and in combination with corticosteroids, is commonly performed in the treatment of tendinopathies. Previous studies have shown that local anaesthetics and corticosteroids are chondrotoxic, but their effect on tenocytes remains unknown. We compared the effects of lidocaine and ropivacaine, alone or combined with dexamethasone, on the viability of cultured bovine tenocytes. Tenocytes were exposed to ten different conditions: 1) normal saline; 2) 1% lidocaine; 3) 2% lidocaine; 4) 0.2% ropivacaine; 5) 0.5% ropivacaine; 6) dexamethasone (dex); 7) 1% lidocaine+dex; 8) 2% lidocaine+dex; 9) 0.2% ropivacaine+dex; and 10) 0.5% ropivacaine+dex, for 30 minutes. After a 24-hour recovery period, the viability of the tenocytes was quantified using the CellTiter-Glo viability assay and fluorescence-activated cell sorting (FACS) for live/dead cell counts. A 30-minute exposure to lidocaine alone was significantly toxic to the tenocytes in a dose-dependent manner, but a 30-minute exposure to ropivacaine or dexamethasone alone was not significantly toxic.

Dexamethasone potentiated ropivacaine tenocyte toxicity at higher doses of ropivacaine, but did not potentiate lidocaine tenocyte toxicity. As seen in other cell types, lidocaine has a dose-dependent toxicity to tenocytes but ropivacaine is not significantly toxic. Although dexamethasone alone is not toxic, its combination with 0.5% ropivacaine significantly increased its toxicity to tenocytes. These findings might be relevant to clinical practice and warrant further investigation.